摘要
目的研究TCT、高危型HPV检测在社区宫颈癌筛查中的临床应用价值。方法选取2017年1月—2018年9月该社区接受高危性HPV和TCT检测的327例妇女为该次研究对象。对比高危性HPV和TCT检测的特异度、灵敏度。结果全部受检者中24例TCT阳性,阳性率为7.34%;41例高危HPV阳性,阳性率为12.54%。高危HPV与TCT检测灵敏度和特异度相比较,组间数据差异有统计学意义(P<0.05)。结论高危型HPV检测与TCT联合筛查能显著降低漏诊率,可用于宫颈癌的初筛。
Objective To study the clinical application value of TCT and high-risk HPV detection in community cervical cancer screening. Methods A total of 327 women who underwent high-risk HPV and TCT testing in the community from January 2017 to September 2018 were selected for the study. Compare the specificity and sensitivity of high-risk HPV and TCT assays. Results 24 patients were positive for TCT in all subjects, the positive rate was 7.34%;41 cases were high-risk HPV positive, the positive rate was 12.54%. Compared with the sensitivity and specificity of high-risk HPV and TCT detection, there was a significant difference between the groups (P<0.05). Conclusion High-risk HPV detection combined with TCT screening can significantly reduce the rate of missed diagnosis and can be used for primary screening of cervical cancer.
作者
犹真明
庄建全
姜玲
YOU Zhen-ming;ZHUANG Jian-quan;JIANG Ling(Chongqing Wansheng Economic Development Zone People's Hospital, Chongqing, 400800 China)
出处
《系统医学》
2019年第16期24-26,共3页
Systems Medicine
